Can they stomach it? Parent and practitioner acceptability of a trial comparing gastric residual volume measurement versus no gastric residual volume in UK NNU and PICUs: a feasibility study.

Acceptability Feasibility Gastric residual volume Intensive care

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
16 Feb 2021
Historique:
received: 20 05 2020
accepted: 26 01 2021
entrez: 17 2 2021
pubmed: 18 2 2021
medline: 18 2 2021
Statut: epublish

Résumé

Routine measurement of gastric residual volume (GRV) to guide feeding in neonatal and paediatric intensive care is widespread. However, this practice is not evidence based and may cause harm. As part of a feasibility study, we explored parent and practitioner views on the acceptability of a trial comparing GRV measurement or no GRV measurement. A mixed-methods study involving interviews and focus groups with practitioners and interviews with parents with experience of tube feeding in neonatal and/or paediatric intensive care. A voting system recorded closed question responses during practitioner data collection, enabling the collection of quantitative and qualitative data. Data were analysed using thematic analysis and descriptive statistics. We interviewed 31 parents and nine practitioners and ran five practitioner focus groups (n=42). Participants described how the research question was logical, and the intervention would not be invasive and potential benefits of not withholding the child's feeds. However, both groups held concerns about the potential risk of not measuring GRV, including delayed diagnosis of infection and gut problems, increased risk of vomiting into lungs and causing discomfort or pain. Parent's views on GRV measurement and consent decision making were influenced by their views on the importance of feeding in the ICU, their child's prognosis and associated comorbidities or complications. The majority of parents and practitioners viewed the proposed trial as acceptable. Potential concerns and preferences were identified that will need careful consideration to inform the development of the proposed trial protocol and staff training.

Sections du résumé

BACKGROUND BACKGROUND
Routine measurement of gastric residual volume (GRV) to guide feeding in neonatal and paediatric intensive care is widespread. However, this practice is not evidence based and may cause harm. As part of a feasibility study, we explored parent and practitioner views on the acceptability of a trial comparing GRV measurement or no GRV measurement.
METHODS METHODS
A mixed-methods study involving interviews and focus groups with practitioners and interviews with parents with experience of tube feeding in neonatal and/or paediatric intensive care. A voting system recorded closed question responses during practitioner data collection, enabling the collection of quantitative and qualitative data. Data were analysed using thematic analysis and descriptive statistics.
RESULTS RESULTS
We interviewed 31 parents and nine practitioners and ran five practitioner focus groups (n=42). Participants described how the research question was logical, and the intervention would not be invasive and potential benefits of not withholding the child's feeds. However, both groups held concerns about the potential risk of not measuring GRV, including delayed diagnosis of infection and gut problems, increased risk of vomiting into lungs and causing discomfort or pain. Parent's views on GRV measurement and consent decision making were influenced by their views on the importance of feeding in the ICU, their child's prognosis and associated comorbidities or complications.
CONCLUSIONS CONCLUSIONS
The majority of parents and practitioners viewed the proposed trial as acceptable. Potential concerns and preferences were identified that will need careful consideration to inform the development of the proposed trial protocol and staff training.

Identifiants

pubmed: 33593416
doi: 10.1186/s40814-021-00784-5
pii: 10.1186/s40814-021-00784-5
pmc: PMC7885383
doi:

Types de publication

Journal Article

Langues

eng

Pagination

49

Subventions

Organisme : the UK National Institute for Health Research Health Technology Assessment programme
ID : (16/94/02)

Références

JPEN J Parenter Enteral Nutr. 2021 Jan;45(1):79-86
pubmed: 32144809
Pediatrics. 2002 Mar;109(3):457-9
pubmed: 11875141
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Intensive Care Med. 2017 Mar;43(3):380-398
pubmed: 28168570
JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):706-742
pubmed: 28686844
Arch Dis Child. 2018 Jan;103(1):28-32
pubmed: 28847877
J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):437-42
pubmed: 19330932
Nurs Crit Care. 2010 Nov-Dec;15(6):291-9
pubmed: 21040260
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
N Engl J Med. 2019 Oct 10;381(15):1434-1443
pubmed: 31597020
Health Technol Assess. 2019 Feb;23(5):1-148
pubmed: 30793698
Int J Nurs Stud. 2013 Nov;50(11):1459-67
pubmed: 23537895
Health Technol Assess. 2014 Jun;18(38):1-197, v-vi
pubmed: 24914457
Pediatrics. 2004 Jan;113(1 Pt 1):50-3
pubmed: 14702446
Contemp Clin Trials Commun. 2017 Nov 23;9:33-39
pubmed: 29696222
Nutrition. 2017 Jan;33:91-95
pubmed: 27364223
Nurs Crit Care. 2017 Sep;22(5):293-297
pubmed: 28640510
Clin Nutr. 2016 Dec;35(6):1226-1235
pubmed: 27181526
JPEN J Parenter Enteral Nutr. 2005 May-Jun;29(3):192-7
pubmed: 15837779
Lancet. 2004 Aug 28-Sep 3;364(9436):803-11
pubmed: 15337409
J Pediatr (Rio J). 2016 May-Jun;92(3):223-9
pubmed: 26854736
BMJ Open. 2015 Sep 18;5(9):e008522
pubmed: 26384724
JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211
pubmed: 26773077
Lancet Gastroenterol Hepatol. 2018 Apr;3(4):281-287
pubmed: 29533200
Pediatr Crit Care Med. 2019 Aug;20(8):707-713
pubmed: 31398180
J Pediatr. 2006 Jul;149(1 Suppl):S31-3
pubmed: 16829240
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
BMJ. 2000 Jan 1;320(7226):50-2
pubmed: 10617534
JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1100-1109
pubmed: 28061320
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Arch Dis Child. 2019 May;104(5):426-431
pubmed: 30087153
Pediatrics. 2011 Jun;127(6):e1471-81
pubmed: 21624876
Newborn Infant Nurs Rev. 2012 Dec 1;12(4):207-213
pubmed: 23204932
BMC Med Ethics. 2013 Nov 06;14:45
pubmed: 24195717
BMC Public Health. 2013 Aug 15;13:756
pubmed: 23947336

Auteurs

Elizabeth Deja (E)

Institute of Population Health, University of Liverpool, Liverpool, UK. E.deja@liverpool.ac.uk.

Louise Roper (L)

Institute of Population Health, University of Liverpool, Liverpool, UK.

Lyvonne N Tume (LN)

School of Health & Society, University of Salford, Manchester, M6 6PU, UK.

Jon Dorling (J)

Division of Pediatrics and Neonatal-Perinatal Medicine, Dalhousie University, Halifax, Canada.

Chris Gale (C)

Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital campus, London, UK.

Barbara Arch (B)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, UK.

Lynne Latten (L)

Department of Dietetics, Alder Hey Children's Hospital, Liverpool, UK.

Nazima Pathan (N)

Paediatric Intensive Care, University of Cambridge, Addenbrooke's Hospital Cambridge, Campbridge, UK.

Helen Eccleson (H)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, UK.

Helen Hickey (H)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, UK.

Jenny Preston (J)

Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Anne Beissel (A)

Neonatal Intensive Care Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon-Bron, France.

Izabela Andrzejewska (I)

Neonatal Intensive Care Unit, Chelsea and Westminster Hospital, London, UK.

Frédéric V Valla (FV)

Faculty of Health & Applied Sciences, University of the West of England, Bristol, UK.
Pediatric Intensive Care Unit, CarMEN INSERM UMR 1060 Equipe INFOLIP, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon-Bron, France.

Kerry Woolfall (K)

Institute of Population Health, University of Liverpool, Liverpool, UK.

Classifications MeSH